Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies
Article in European Journal of Pharmaceutical Sciences (December 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in European Journal of Pharmaceutical Sciences (December 2023)
Article in Hämostaseologie (January 2023)
Article in Molecular Cancer (February 2018)